Sandra Kurtin, PhD, ANP-C, AOCN, on Aggressive B-Cell Lymphoma After Failure of Anti-CD19 CAR T-Cell Therapy: Outcomes and Treatment Patterns

Sandra Kurtin, PhD, ANP-C, AOCN, of the University of Arizona Cancer Center, discusses the largest reported analysis to date of patients with aggressive B-cell lymphoma who developed progressive disease after CAR T-cell therapy. This is of special interest to advanced practitioners, since there is little guidance on the optimal treatment approaches for these patients (Abstract 884).